Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats

Abstract

Studies have shown that the angiotensin II (Ang II) AT 1 receptor antagonist, losartan, accentuates the orthostatic hypotensive response in anesthetized rats, and there is evidence indicating that this effect is not exclusively mediated by AT 1 receptors. We investigated whether the pronounced orthostatic cardiovascular response observed in losartan-treated rats involves an interference with angiotensin-(1-7) (Ang-(1-7)) receptors. Urethane-anesthetized rats were submitted to orthostatic stress (90° head-up tilt for 2 min). Intravenous injection of losartan (1 mg kg -1, n = 9) significantly accentuated the decrease in mean arterial pressure (MAP) induced by head-up tilt (-33±6% after losartan vs -15±8% control tilt). This effect was accompanied by a significant bradycardia (-8±3% after losartan vs -3±3% control tilt). Another AT 1 antagonist, candesartan, did not potentiate the decrease of MAP and did not change the cardiac response induced by head-up tilt. Strikingly, administration of the Ang-(1-7) antagonist, A-779 (10 nmol kg -1, n = 5), totally reversed the bradicardiac effect caused by losartan and this effect was accompanied by a tendency towards attenuation of the hypotensive response caused by losartan. These findings indicate that the marked orthostatic cardiovascular response is specific for losartan, and that it may be due, in part, to an interaction of this antagonist with Ang-(1-7) receptors, probably at the cardiac level. © 2005 Nature Publishing Group All rights reserved.